Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

Vitamin D supplements improve markers of bone turnover in CKD
Vitamin D supplements improve markers of bone turnover in CKD
(HealthDay)—For patients with chronic kidney disease (CKD), cholecalciferol supplementation can correct vitamin D deficiency and improve markers of bone turnover, according to a stud...
FDA declines to approve PTC's Duchenne drug
FDA declines to approve PTC's Duchenne drug
(Reuters) - The U.
Pfizer to launch consumer health sale in November
Pfizer to launch consumer health sale in November
LONDON (Reuters) - Pfizer plans to kick off an auction process for its consumer healthcare business in November, paving the way for a potential $15 billion-plus sale of the headache pill to li...
Perrigo gets tentative FDA approval for Picato Gel generic
Perrigo gets tentative FDA approval for Picato Gel generic
SILVER SPRING, Md.
Impax launches generic Renvela
Impax launches generic Renvela
HAYWARD, Calif.
Alector and AbbVie Announce Collaboration to Advance a Novel Class of Immune Therapies for Patients with Alzheimer's Disease
Alector and AbbVie Announce Collaboration to Advance a Novel Class of Immune Therapies for Patients with Alzheimer's Disease
NORTH CHICAGO, Ill.
Lilly powers ahead with plant investment even as it cuts 3,500 jobs
Lilly powers ahead with plant investment even as it cuts 3,500 jobs
Even as pricing pressure on its diabetes portfolio led Eli Lilly to cut 3,500 jobs by year-end, the drugmaker today said it is moving forward with a $72 million upgrade to its insulin manufacturing, p...
Can cancer charity efforts from Roche, Bristol, AbbVie and more boost pharma's reputation?
Can cancer charity efforts from Roche, Bristol, AbbVie and more boost pharma's reputation?
Big pharma companies signed on to two big-name cancer efforts—the NIH’s Cancer Moonshot and celebrity-heavy charity Stand Up 2 Cancer—that just might help burnish their industry’s standing.
Dr. Reddy's, fighting to recover from FDA warning letter, recalls 500K heartburn tablets
Dr. Reddy's, fighting to recover from FDA warning letter, recalls 500K heartburn tablets
Still struggling to turn its manufacturing around, Dr.
FDA warns Meridian of violations for lead-testing devices
FDA warns Meridian of violations for lead-testing devices
(Reuters) - The U.
US FDA approves new easy-to-use, once-weekly Bydureon BCise injectable medicine for patients with type-2 diabetes
US FDA approves new easy-to-use, once-weekly Bydureon BCise injectable medicine for patients with type-2 diabetes
LONDON, UK I October 23, 2017 I AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved Bydureon BCise (exenatide extended-release) injectable suspensio...
Bayer makes 2 consumer health appointments
Bayer makes 2 consumer health appointments
WHIPPANY, N.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand